Published in J Biol Chem on February 10, 1981
ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets. Proc Natl Acad Sci U S A (1984) 1.04
Retention of the glycoprotein IIb-IIIa complex in the isolated platelet cytoskeleton. Effects of separable assembly of platelet pseudopodal and contractile cytoskeletons. J Clin Invest (1984) 0.91
Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets. Br J Pharmacol (1984) 0.83
Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest (1979) 4.12
Structure of the platelet membrane glycoprotein IIb. Homology to the alpha subunits of the vitronectin and fibronectin membrane receptors. J Biol Chem (1987) 2.93
Effect of heparin on the activation of factor XII and the contact system in plasma. Thromb Haemost (1991) 2.29
Platelet function in hyperlipoproteinemia. N Engl J Med (1974) 2.23
Kallikrein-kinin system in inflammatory bowel diseases: Intestinal involvement and correlation with the degree of tissue inflammation. Dig Liver Dis (2005) 2.18
Examination of the platelet membrane glycoprotein IIb-IIIa complex and its interaction with fibrinogen and other ligands by electron microscopy. J Biol Chem (1992) 2.18
Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. N Engl J Med (1983) 2.18
Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg (1996) 2.11
Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. J Biol Chem (1983) 2.09
Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody. Proc Natl Acad Sci U S A (1983) 2.09
Interaction of plasma kallikrein with the C1 inhibitor. J Immunol (1970) 2.07
Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor alpha-subunits and platelet glycoprotein IIb. Biochemistry (1987) 1.99
The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem (1985) 1.91
Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest (1975) 1.88
Disseminated intravascular coagulation (DIC): an approach. Am J Med (1972) 1.87
Oligomerization of the integrin alphaIIbbeta3: roles of the transmembrane and cytoplasmic domains. Proc Natl Acad Sci U S A (2001) 1.74
Long range propagation of conformational changes in integrin alpha IIb beta 3. J Biol Chem (1993) 1.73
Affinity labeling of purine nucleotide sites in proteins. Annu Rev Biochem (1983) 1.71
Identification by mutagenesis of arginines in the substrate binding site of the porcine NADP-dependent isocitrate dehydrogenase. J Biol Chem (2000) 1.69
Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci U S A (1976) 1.69
Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med (1992) 1.65
Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med (1969) 1.62
Purification and characterization of a potent 70-kDa thiol lysyl-proteinase (Lys-gingivain) from Porphyromonas gingivalis that cleaves kininogens and fibrinogen. J Biol Chem (1993) 1.61
Identification of the fibrinogen receptor on human platelets by photoaffinity labeling. J Biol Chem (1982) 1.58
Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest (1975) 1.55
Plasma kallikrein and Hageman factor in Gram-negative bacteremia. Ann Intern Med (1970) 1.53
Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins. J Clin Invest (1969) 1.52
On the role of amino groups in the structure and function of glutamate dehydrogenase. I. Effect of acetylation on catalytic and regulatory properties. J Biol Chem (1966) 1.47
Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J Clin Invest (1982) 1.45
The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states. Ann Intern Med (1969) 1.45
Activation of plasminogen by human plasma kallikrein. Biochem Biophys Res Commun (1969) 1.44
Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J Clin Invest (1977) 1.42
Lack of clinically significant contact system activation during platelet concentrate filtration by leukocyte removal filters. Blood (1998) 1.42
Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen. Biochemistry (1981) 1.41
On the role of amino groups in the structure and function of glutamate dehydrogenase. II. Effect of acetylation on molecular properties. J Biol Chem (1966) 1.41
Invited letter concerning: aprotinin. J Thorac Cardiovasc Surg (1991) 1.40
Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor. J Clin Invest (1984) 1.40
Chemical characterization of distinct subunits of pig heart DPN-specific isocitrate dehydrogenase. J Biol Chem (1980) 1.39
Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. Blood (1986) 1.38
The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J Clin Invest (1993) 1.38
The chemical society. Can Med Assoc J (1978) 1.37
Surface-mediated defense reactions. The plasma contact activation system. J Clin Invest (1984) 1.35
Influence of substrates and coenzymes on the role of manganous ion in reactions catalyzed by pig heart triphosphopyridine nucleotide-dependent isocitrate dehydrogenase. Biochemistry (1976) 1.34
Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein. J Clin Invest (1969) 1.34
Synthesis and degradation of mixed proteins, and composition changes in skeletal muscle of malnourished and refed rats. J Nutr (1971) 1.33
More on kininogen measurements in platelet concentrates that are white cell (WBC) reduced with WBC-reduction filters. Transfusion (1996) 1.33
Effect of calcium on the stability of the platelet membrane glycoprotein IIb-IIIa complex. J Biol Chem (1985) 1.31
The genomic organization of platelet glycoprotein IIIa. J Biol Chem (1990) 1.29
Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis (1985) 1.27
Affinity labeling of rabbit muscle pyruvate kinase by 5'-p-fluorosulfonylbenzoyladenosine. Biochemistry (1977) 1.27
Circulating anticoagulants to factor VIII. Immunochemical studies and clinical response to factor VIII concentrates. Am J Med (1970) 1.26
Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. Biochemistry (1984) 1.25
Hypouricemia in Hodgkin's disease. Ann Intern Med (1972) 1.25
Origin of the high molecular weight activator of prekallikrein. J Biol Chem (1973) 1.22
Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest (1983) 1.22
Structure of platelet glycoprotein IIIa. A common subunit for two different membrane receptors. J Clin Invest (1988) 1.22
Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis. Blood (2000) 1.22
Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen. J Clin Invest (1982) 1.21
Formation of human plasma kinin. N Engl J Med (1974) 1.21
Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with the platelet surface. J Clin Invest (1980) 1.20
The activation state of alphavbeta 3 regulates platelet and lymphocyte adhesion to intact and thrombin-cleaved osteopontin. J Biol Chem (2000) 1.19
Human plasma prekallikrein: a rapid high-yield method for purification. Eur J Biochem (1979) 1.17
The regulation of human factor XIIa by plasma proteinase inhibitors. J Biol Chem (1985) 1.17
Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb (1992) 1.16
Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. J Clin Invest (1975) 1.16
A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. N Engl J Med (1970) 1.14
Purified human plasma kallikrein aggregates human blood neutrophils. J Clin Invest (1982) 1.13
Diphosphopyridine nucleotide dependent isocitrate dehydrogenase from pig heart. Charactgerization of the active substrate and modes of regulation. Biochemistry (1972) 1.13
Identification of adenine nucleotide binding proteins in human platelet membranes by affinity labeling with 5'-p-flurosulfonylbenzoyl adenosine. J Biol Chem (1978) 1.11
Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies. J Biol Chem (1992) 1.11
Mechanisms for the oxidative decarboxylation of isocitrate: implications for control. Adv Enzyme Regul (1975) 1.10
Subcellular localization and secretion of factor V from human platelets. Proc Natl Acad Sci U S A (1981) 1.09
Critical role of the carbohydrate side chains of collagen in platelet aggregation. J Clin Invest (1972) 1.09
Cyclic AMP metabolism in cholesterol-rich platelets. J Biol Chem (1977) 1.09
Chromosomal localization of the genes for the vitronectin and fibronectin receptors alpha subunits and for platelet glycoproteins IIb and IIIa. J Clin Invest (1988) 1.09
A primate model of hyperacute renal allograft rejection. Am J Pathol (1975) 1.09
Adenosine derivatives for dehydrogenases and kinases. Methods Enzymol (1977) 1.08
Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation (1996) 1.08
Glutamate dehydrogenase concentration as a determinant in the effect of purine nucleotides on enzymatic activity. J Biol Chem (1967) 1.07
Human neutrophils contain and bind high molecular weight kininogen. J Clin Invest (1989) 1.07
The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy. J Biol Chem (1994) 1.06
What the community physician can do for Indochinese refugees. Can Med Assoc J (1979) 1.06
Chronic intravascular coagulation syndrome. N Engl J Med (1968) 1.06
Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen. FASEB J (2001) 1.05
Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf. J Clin Invest (1986) 1.05
Disseminated intravascular coagulation. Approach to treatment. Drugs (1992) 1.04
Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation. J Clin Invest (1988) 1.03
Effect of single amino acid substitutions on the formation of the PlA and Bak alloantigenic epitopes. Blood (1991) 1.03
Organization of the gene for platelet glycoprotein IIb. Biochemistry (1990) 1.03
High-molecular weight kininogen. A secreted platelet protein. J Clin Invest (1983) 1.03